KCNQ1 variants and response to repaglinide treatment in patients with Type 2 diabetes.

Pharmacogenomics ·Vol. 13 ·No. 12 ·2012-09-00 ·Pages 1329-30

Tkáč I

Abstract

暂无摘要

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Tkáč Ivan

Department of Internal Medicine 4, L. Pasteur University Hospital, P. J. Šafárik University, Košice, Slovakia. [email protected]

Article Info

Journal

Pharmacogenomics

Abbr.

Pharmacogenomics

ISSN

1744-8042

DOI

Published

2012-09-00

Pages

1329-30

Language

English

Region

England

NLM ID

100897350

Corrections

CommentOn

PMID: 22414228

External Links

Analysis Services